Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
F. Ramalho Fernandes (Guarda, Portugal), T. Almodovar (Lisboa, Portugal), I. Duarte (Lisboa, Portugal), D. Costa (Lisboa, Portugal). Immune Checkpoint Inhibitors-related Intersticial Lung Disease in patients with thoracic tumors: experience of one institution. 2858

Member's Comments

No comment yet.

Related content which might interest you: Outcome of patients with non specific pleuritis after medical thoracoscopy Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Survival in lung cancer: Associated factors in Tunisian patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 The role of Radiological follow-up protocol in patients with surgically resected Non-Small Cell Lung Cancer. Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 The Role Of TGF-ß in Lung Cancer Development in COPD Patients Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Treatment of pulmonary carcinoid: Are there new options? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Radiation pneumonitis; early diagnosis and associated factors Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST) Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings Year: 2018 Parasympathetic Nervous System withdrawal in patients with Interstitial Lung Disease but not in COPD patients Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Associated Factors with the Approval of Pulmonary Rehabilitation for Inpatients with Interstitial Lung Disease: Two-center Retrospective Study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Medical thoracoscopy in the diagnosis and treatment of lung/pleural disease: Sharing an experience of 1125 cases Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases Year: 2013 Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Causes of Hospitalization and Mortality in Lung Cancer Patients Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Immune-Related Adverse Events Associated with Immune Checkpoint Blockade in Lung Cancer – A restrospective study. Source: International Congress 2019 – Treatment of lung cancer Year: 2019